Skip to content

Nessi Spacer

by Pharmacaribe

510(k) K091862

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 5 Oct 2026

Documents

Trust

Unverified

Source FDA 510(k), synced 5 Oct 2026.

Regulatory status

as of registry sync 5 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK091862 Date20 Nov 2009ClearedStatusActive

Official records

From the FDA record

Received by the FDA
23 Jun 2009
FDA decision
20 Nov 2009 (Substantially Equivalent)
FDA review time
150 days from receipt to decision
Public document
510(k) summary on file with the FDA

From the FDA 510(k) record K091862 (openFDA), as read on 5 Oct 2026. Quoted as published, gaps included; nothing on this list is generated.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA product code
NVO
Device class
Class II
Regulation
21 CFR Part 868.5630
Advisory committee
Anesthesiology
FDA decision
SESE Substantially Equivalent

Overview

AI-generated summary, 1 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Nessi Spacer is a medical delivery apparatus classified as a spacer for metered dose inhalers. It functions as a chamber positioned between the inhaler canister and the patient’s mouth, designed to slow and evaporate medication droplets. This reduces direct contact with the oropharynx, enhancing the deposition of medication in the lower respiratory tract. Its primary purpose aligns with the device type ‘Spacer, Direct Patient Interface’ as defined by regulatory nomenclature.

The Nessi Spacer is supplied as a single-use device and is intended for use in clinical settings, particularly within anesthesiology. It is not sterilised post-manufacture but is packaged in a manner suitable for direct patient use. The device is classified under FDA regulation number 868.5630 and holds a 510(k) clearance (K091862) for substantial equivalence. No additional regulatory markings or MRI safety classifications are specified in the available data.

Other devices from Pharmacaribe LLC